JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Mapatumumab is a human monoclonal antibody which targets human Tumor necrosis factor receptor superfamily member 10A (TRAIL-R1, CD261).